Page 56 - Read Online

Morgan et al. HOX genes and the tumor microenvironment

2. Huang Y, Yuan J, Righi E, Kamoun WS, Ancukiewicz M, Nezivar J, in developing and cycling murine hair follicles. Mech Dev
Santosuosso M, Martin JD, Martin MR, Vianello F, Leblanc P, Munn 2002;113:207-10.
LL, Huang P, Duda DG, Fukumura D, Jain RK, Poznansky MC. 23. Morgan R, El-Tanani M, Hunter KD, Harrington KJ, Pandha HS.
Vascular normalizing doses of antiangiogenic treatment reprogram Targeting HOX/PBX dimers in cancer. Oncotarget 2017;8:32322-31.
the immunosuppressive tumor microenvironment and enhance 24. Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C, Michael
immunotherapy. Proc Natl Acad Sci U S A 2012;109:17561-6. A, Pandha HS. Targeting the HOX/PBX dimer in breast cancer.
3. Niu YN, Xia SJ. Stroma-epithelium crosstalk in prostate cancer. Breast Cancer Res Treat 2012;136:389-98.
Asian J Androl 2009;11:28-35. 25. Morgan R, Boxall A, Harrington KJ, Simpson GR, Michael A,
4. Yoneda T, Hiraga T. Crosstalk between cancer cells and bone Pandha HS. Targeting HOX transcription factors in prostate cancer.
microenvironment in bone metastasis. Biochem Biophys Res Commun BMC Urol 2014;14:17.
2005;328:679-87. 26. Morgan R, Pirard PM, Shears L, Sohal J, Pettengell R, Pandha
5. Mallo M, Wellik DM, Deschamps J. Hox genes and regional HS. Antagonism of HOX/PBX dimer formation blocks the in vivo
patterning of the vertebrate body plan. Dev Biol 2010;344:7-15. proliferation of melanoma. Cancer Res 2007;67:5806-13.
6. Gehring WJ. Homeo boxes in the study of development. Science 27. Morgan R, Simpson G, Gray S, Gillett C, Tabi Z, Spicer J, Harrington
1987;236:1245-52. KJ, Pandha HS. HOX transcription factors are potential targets and
7. Holland PW, Booth HA, Bruford EA. Classification and nomenclature markers in malignant mesothelioma. BMC Cancer 2015;16:85.
of all human homeobox genes. BMC Biol 2007;5:47. 28. Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS.
8. Platais C, Hakami F, Darda L, Lambert DW, Morgan R, Hunter KD. Targeting HOX and PBX transcription factors in ovarian cancer.
The role of HOX genes in head and neck squamous cell carcinoma. J BMC Cancer 2010;10:89.
Oral Pathol Med 2016;45:239-47. 29. Plowright L, Harrington KJ, Pandha HS, Morgan R. HOX transcription
9. Longobardi E, Penkov D, Mateos D, De Florian G, Torres M, Blasi F. factors are potential therapeutic targets in non-small-cell lung cancer
Biochemistry of the tale transcription factors PREP, MEIS, and PBX (targeting HOX genes in lung cancer). Br J Cancer 2009;100:470-5.
in vertebrates. Dev Dyn 2014;243:59-75. 30. Ducruet AP, Vogt A, Wipf P, Lazo JS. Dual specificity protein
10. Allen TD, Zhu YX, Hawley TS, Hawley RG. TALE homeoproteins phosphatases: therapeutic targets for cancer and Alzheimer’s disease.
as HOX11-interacting partners in T-cell leukemia. Leuk Lymphoma Annu Rev Pharmacol Toxicol 2005;45:725-50.
2000;39:241-56. 31. Eichhorst ST, Muller M, Li-Weber M, Schulze-Bergkamen H, Angel
11. Brendolan A, Ferretti E, Salsi V, Moses K, Quaggin S, Blasi F, Cleary P, Krammer PH. A novel AP-1 element in the CD95 ligand promoter
ML, Selleri L. A Pbx1-dependent genetic and transcriptional network is required for induction of apoptosis in hepatocellular carcinoma cells
regulates spleen ontogeny. Development 2005;132:3113-26. upon treatment with anticancer drugs. Mol Cell Biol 2000;20:7826-37.
12. Piper DE, Batchelor AH, Chang CP, Cleary ML, Wolberger C. 32. Grimm C, Wenzel A, Behrens A, Hafezi F, Wagner EF, Remé CE. AP-1
Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the mediated retinal photoreceptor apoptosis is independent of N-terminal
hexapeptide and a fourth homeodomain helix in complex formation. phosphorylation of c-Jun. Cell Death Differ 2001;8:859-67.
Cell 1999;96:587-97. 33. Hafezi F, Grimm C, Wenzel A, Abegg M, Yaniv M, Reme CE. Retinal
13. Williams TM, Williams ME, Innis JW. Range of HOX/TALE photoreceptors are apoptosis-competent in the absence of JunD/AP-1.
superclass associations and protein domain requirements for Cell Death Differ 1999;6:934-6.
HOXA13:MEIS interaction. Dev Biol 2005;277:457-71. 34. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A,
14. Di-Poi N, Koch U, Radtke F, Duboule D. Additive and global Green DR. DNA damaging agents induce expression of Fas ligand
functions of HoxA cluster genes in mesoderm derivatives. Dev Biol and subsequent apoptosis in T lymphocytes via the activation of NF-
2010;341:488-98. kappa B and AP-1. Mol Cell 1998;1:543-51.
15. Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive 35. Kolbus A, Herr I, Schreiber M, Debatin KM, Wagner EF, Angel
lymphoid-myeloid engraftment potential on embryonic stem cell and P. c-Jun-dependent CD95-L expression is a rate-limiting step in
yolk sac hematopoietic progenitors. Cell 2002;109:29-37. the induction of apoptosis by alkylating agents. Mol Cell Biol
16. Lebert-Ghali CE, Fournier M, Dickson GJ, Thompson A, Sauvageau G, 2000;20:575-82.
Bijl JJ. HoxA cluster is haploinsufficient for activity of hematopoietic 36. Rubin E, Wu X, Zhu T, Cheung JC, Chen H, Lorincz A, Pandita RK,
stem and progenitor cells. Exp Hematol 2010;38:1074-86.e1-5. Sharma GG, Ha HC, Gasson J, Hanakahi LA, Pandita TK, Sukumar
17. Xu B, Geerts D, Bu Z, Ai J, Jin L, Li Y, Zhang H, Zhu G. Regulation S. A role for the HOXB7 homeodomain protein in DNA repair.
of endometrial receptivity by the highly expressed HOXA9, Cancer Res 2007;67:1527-35.
HOXA11 and HOXD10 HOX-class homeobox genes. Hum Reprod 37. Gabellini D, Colaluca IN, Vodermaier HC, Biamonti G, Giacca M,
2014;29:781-90. Falaschi A, Riva S, Peverali FA. Early mitotic degradation of the
18. Rux DR, Song JY, Swinehart IT, Pineault KM, Schlientz AJ, homeoprotein HOXC10 is potentially linked to cell cycle progression.
Trulik KG, Goldstein SA, Kozloff KM, Lucas D, Wellik DM. EMBO J 2003;22:3715-24.
Regionally restricted Hox function in adult bone marrow multipotent 38. Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN,
mesenchymal stem/stromal cells. Dev Cell 2016;39:653-66. Schirripa O, Lucia MS, Nordeen SK. Aberrant HOXC expression
19. Alharbi RA, Pettengell R, Pandha HS, Morgan R. The role of HOX accompanies the malignant phenotype in human prostate. Cancer Res
genes in normal hematopoiesis and acute leukemia. Leukemia 2003;63:5879-88.
2013;27:1000-8. 39. Waltregny D, Alami Y, Clausse N, de Leval J, Castronovo V.
20. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Overexpression of the homeobox gene HOXC8 in human prostate
Nat Rev Cancer 2010;10:361-71. cancer correlates with loss of tumor differentiation. Prostate
21. Asuthkar S, Stepanova V, Lebedeva T, Holterman AL, Estes N, 2002;50:162-9.
Cines DB, Rao JS, Gondi CS. Multifunctional roles of urokinase 40. Hamid AR, Hoogland AM, Smit F, Jannink S, van Rijt-van de
plasminogen activator (uPA) in cancer stemness and chemoresistance Westerlo C, Jansen CF, van Leenders GJ, Verhaegh GW, Schalken
of pancreatic cancer. Mol Biol Cell 2013;24:2620-32. JA. The role of HOXC6 in prostate cancer development. Prostate
22. Shang L, Pruett ND, Awgulewitsch A. Hoxc12 expression pattern 2015;75:1868-76.
284 Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ December 6, 2017